Search Results

Canadians now have access to Luxturna!

Luxturna is the first gene therapy treatment approved for an inherited retinal disease in Canada. The treatment is for people who have Leber congenital amaurosis (LCA) or retinitis pigmentosa (RP) caused by...

Advances in Stem Cell Therapy made by FBC-Funded Researcher

Cells Grown in Lab can Reach Out and Connect to Other Retina Cells Fighting Blindness Canada (FBC) funded scientist Dr. David Gamm (University of Wisconsin) has successfully shown that photoreceptor cells grown...

Their parents thought they were afraid of the dark. Then these twins learned the truth — and the fight to save their sight began

Nathan and Andre needed a game-changing gene-specific therapy. But the costs were astronomical and the parents were at a loss. Here’s how I witnessed their story go from tragic to triumphant. Twins...

Developing a new therapy for age-related macular degeneration and diabetic retinopathy.

Dr. Sachdev Sidhu (University of Toronto) is a biomedical engineer with extensive experience in drug development. Dr. Sidhu established the Toronto Recombinant Antibody Centre (TRAC) which houses a state-of-the-art platform to generate...

FBC scientists collaborate to identify new gene for retinitis pigmentosa

Teamwork really does make the dream work! We are excited to share news of a Fighting Blindness Canada (FBC) funded discovery recently published in the journal Science Advances achieved through a collaboration...

Join the Fight!

Learn how your support is helping to bring a future without blindness into focus! Be the first to learn about the latest breakthroughs in vision research and events in your community by subscribing to our e-newsletter that lands in inboxes the beginning of each month.